Credit Suisse’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-58,256
| Closed | -$1.91M | – | 4545 |
|
|
2022
Q2 | $1.91M | Buy |
58,256
+26,871
| +86% | +$849K | ﹤0.01% | 1954 |
|
|
2022
Q1 | $825K | Buy |
31,385
+2,612
| +9% | +$63.8K | ﹤0.01% | 2662 |
|
|
2021
Q4 | $683K | Buy |
28,773
+1,940
| +7% | +$47.9K | ﹤0.01% | 3609 |
|
|
2021
Q3 | $673K | Sell |
26,833
-4,909
| -15% | -$125K | ﹤0.01% | 3616 |
|
|
2021
Q2 | $825K | Sell |
31,742
-5,018
| -14% | -$137K | ﹤0.01% | 3528 |
|
|
2021
Q1 | $942K | Sell |
36,760
-6,611
| -15% | -$169K | ﹤0.01% | 3359 |
|
|
2020
Q4 | $870K | Buy |
43,371
+13,609
| +46% | +$267K | ﹤0.01% | 3426 |
|
|
2020
Q3 | $509K | Sell |
29,762
-336
| -1% | -$6.35K | ﹤0.01% | 3388 |
|
|
2020
Q2 | $657K | Sell |
30,098
-2,979
| -9% | -$68.2K | ﹤0.01% | 3160 |
|
|
2020
Q1 | $765K | Buy |
33,077
+1,297
| +4% | +$37.7K | ﹤0.01% | 2864 |
|
|
2019
Q4 | $1.05M | Buy |
31,780
+1,300
| +4% | +$41.7K | ﹤0.01% | 3080 |
|
|
2019
Q3 | $971K | Buy |
30,480
+1,511
| +5% | +$44K | ﹤0.01% | 3036 |
|
|
2019
Q2 | $745K | Sell |
28,969
-3,182
| -10% | -$81.1K | ﹤0.01% | 3148 |
|
|
2019
Q1 | $815K | Buy |
32,151
+4,030
| +14% | +$120K | ﹤0.01% | 3046 |
|
|
2018
Q4 | $957K | Buy |
28,121
+1,864
| +7% | +$60.6K | ﹤0.01% | 2804 |
|
|
2018
Q3 | $936K | Sell |
26,257
-10,104
| -28% | -$357K | ﹤0.01% | 2919 |
|
|
2018
Q2 | $1.25M | Buy |
36,361
+436
| +1% | +$15.3K | ﹤0.01% | 2842 |
|
|
2018
Q1 | $1.21M | Buy |
35,925
+1,609
| +5% | +$50.9K | ﹤0.01% | 2826 |
|
|
2017
Q4 | $1.31M | Sell |
34,316
-9,205
| -21% | -$367K | ﹤0.01% | 2785 |
|
|
2017
Q3 | $1.63M | Buy |
43,521
+18,626
| +75% | +$657K | ﹤0.01% | 2721 |
|
|
2017
Q2 | $929K | Sell |
24,895
-7,056
| -22% | -$255K | ﹤0.01% | 2751 |
|
|
2017
Q1 | $1.25M | Sell |
31,951
-36,296
| -53% | -$1.36M | ﹤0.01% | 2687 |
|
|
2016
Q4 | $2.37M | Buy |
68,247
+35,464
| +108% | +$1.39M | ﹤0.01% | 2303 |
|
|
2016
Q3 | $1.29M | Buy |
32,783
+2,817
| +9% | +$112K | ﹤0.01% | 2744 |
|
|
2016
Q2 | $1.13M | Buy |
29,966
+11,022
| +58% | +$369K | ﹤0.01% | 2821 |
|
|
2016
Q1 | $727K | Sell |
18,944
-7,060
| -27% | -$263K | ﹤0.01% | 2969 |
|
|
2015
Q4 | $1.25M | Sell |
26,004
-22,383
| -46% | -$1.04M | ﹤0.01% | 2640 |
|
|
2015
Q3 | $1.91M | Buy |
48,387
+15,241
| +46% | +$648K | ﹤0.01% | 2293 |
|
|
2015
Q2 | $1.41M | Buy |
33,146
+10,224
| +45% | +$407K | ﹤0.01% | 2856 |
|
|
2015
Q1 | $904K | Sell |
22,922
-8,593
| -27% | -$317K | ﹤0.01% | 3058 |
|
|
2014
Q4 | $1.14M | Sell |
31,515
-11,918
| -27% | -$400K | ﹤0.01% | 3024 |
|
|
2014
Q3 | $1.28M | Sell |
43,433
-26,213
| -38% | -$723K | ﹤0.01% | 2841 |
|
|
2014
Q2 | $1.75M | Sell |
69,646
-23,012
| -25% | -$569K | ﹤0.01% | 2834 |
|
|
2014
Q1 | $2.39M | Buy |
92,658
+42,106
| +83% | +$1.06M | ﹤0.01% | 2382 |
|
|
2013
Q4 | $1.14M | Buy |
50,552
+26,031
| +106% | +$503K | ﹤0.01% | 3159 |
|
|
2013
Q3 | $348K | Sell |
24,521
-3,749
| -13% | -$50.1K | ﹤0.01% | 3714 |
|
|
2013
Q2 | $386K | Buy |
+28,270
| New | +$385K | ﹤0.01% | 3475 |
|
Other funds holding NTUS
Credit Suisse's NTUS Position: Q3 2022 in Review
Credit Suisse sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 58,256 shares — an estimated $1.91M sold.
Credit Suisse first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $2.39M in Q1 2014. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Credit Suisse reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Credit Suisse sold 58,256 Natus Medical Inc shares in Q3 2022, an estimated $1.91M.
- Credit Suisse first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
- Credit Suisse's Natus Medical Inc position peaked at $2.39M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.